Skip to content
Citation only via Europe PMC

Lepr Haploinsufficiency Accelerates Alzheimer-like Neurodegeneration via CDK5 Hyperactivation.

Paul S, Bhardwaj J, Sharma S, Swalih M, Koul D, Bk B.

The Journal of biological chemistry · 2026

Abstract

Leptin receptor (LEPR) signaling plays a critical role in neuronal survival and synaptic function and is increasingly implicated in Alzheimer's disease (AD) pathogenesis. Beyond its metabolic actions, leptin regulates β-amyloid homeostasis, tau phosphorylation, and synaptic plasticity. While the neurological consequences of homozygous leptin receptor (Lepr) mutations are well characterized, the impact of heterozygous Lepr deficiency on brain aging and neurodegeneration remains unclear. To address this, we analyzed heterozygous leptin receptor mutant (db/+) mice at 6 and 12 months of age using metabolic, behavioral, biochemical, neuropathological, and transcriptomic approaches. Young db/+ mice were comparable to controls, whereas aged db/+ mice developed obesity, impaired glucose tolerance, and insulin resistance, accompanied by deficits in spatial learning and motor coordination. Aged db/+ brains exhibited elevated amyloid-β42 levels, increased CDK5 kinase activity, and hyperphosphorylation of tau at Ser396 and Thr231. Although total LEPR protein levels were unchanged, phosphorylation of STAT3 at Tyr705 was significantly reduced, indicating impaired downstream LEPR signaling. Transcriptomic profiling revealed downregulation of genes involved in synaptic signaling and plasticity, including Gabrb2, Brsk1, Camk2a, Syn1, and Syngap1, along with alterations in neurotransmitter and oxidative phosphorylation pathways. Collectively, these findings demonstrate that leptin receptor haploinsufficiency promotes age-dependent metabolic dysfunction, synaptic failure, and CDK5-mediated tauopathy, leading to Alzheimer-like neurodegeneration and identifying LEPR as a potential genetic risk factor and therapeutic target.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
Europe PMC
DOI
10.1016/j.jbc.2026.113749
Canonical
link ↗
Fetched
2026-11-15 MST

Cite this

APA
S, P., J, B., S, S., M, S., D, K., &amp; B., B. (2026). Lepr Haploinsufficiency Accelerates Alzheimer-like Neurodegeneration via CDK5 Hyperactivation. <em>The Journal of biological chemistry</em>. https://doi.org/10.1016/j.jbc.2026.113749
Vancouver
S P, J B, S S, M S, D K, B. B. Lepr Haploinsufficiency Accelerates Alzheimer-like Neurodegeneration via CDK5 Hyperactivation. The Journal of biological chemistry. 2026. doi:10.1016/j.jbc.2026.113749.
BibTeX
@article{paul2026LeprHa, title = {Lepr Haploinsufficiency Accelerates Alzheimer-like Neurodegeneration via CDK5 Hyperactivation.}, author = {Paul S and Bhardwaj J and Sharma S and Swalih M and Koul D and Bk B.}, journal = {The Journal of biological chemistry}, year = {2026}, doi = {10.1016/j.jbc.2026.113749}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings